Amgen To Issue Biotech Cost-Effectiveness Study For Key Therapeutic Areas
This article was originally published in The Pink Sheet Daily
Executive Summary
The “Value of Biotechnology” study will examine the impact of biotech products on the social and economic burden of diseases such as asthma, stroke and diabetes.